North Springs Resources Corp. (OTC PINK:NSRS) is pleased to announce that the Company has entered the final stage of preparation to bring state-of-the-art pharmaceutical, Poten, to the marketplace; a new emerging treatment for erectile dysfunction. In expectation of a strong launch, the Company mobilizes to meet robust anticipated demand.
Due to patent expirations expected to span the next few years, the window of opportunity swings open for viable contenders like Poten to gain market share. According to a recent report, key drivers of this market include an increase in patient awareness and education levels and growing base of geriatric population. Rising adoption of a sedentary lifestyle and increasing incidence of lifestyle diseases are further anticipated to fuel growth. North America constituted the largest share of approximately 55.0 percent in 2013 of the total erectile dysfunction market.
“This is a very exciting milestone for us. Our entrance into the erectile dysfunction segment is an outstanding addition to what we have developed thus far. As we continue to develop our revenue streams, our intent is to bolster our position in the pharmaceutical marketplace by acquiring high-quality and effective medicinal solutions,” stated J. Douglas Pulver, President of North Springs Resources Corp.
The Company will be keeping shareholders updated regarding progress with the FDA, manufacturing, marketing strategies, and market entrance.
Erectile dysfunction (ED) can be described as the frequent inability for a man to attain and sustain an erection; this could inhibit sexual intercourse and affect quality of life. Onset of ED can begin at the age of 40 and affects 18 to 30 million men. Occasional failure to achieve an erection is not uncommon but a prevalence of 50% or more of the time could be an indication that treatment is required.
